nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—ALB—ulcerative colitis	0.463	1	CbGaD
Valsartan—SLCO1B1—Sulfasalazine—ulcerative colitis	0.117	0.434	CbGbCtD
Valsartan—ALB—Prednisone—ulcerative colitis	0.0512	0.19	CbGbCtD
Valsartan—CYP2C9—Nicotine—ulcerative colitis	0.0444	0.165	CbGbCtD
Valsartan—CYP2C9—Cholecalciferol—ulcerative colitis	0.0398	0.148	CbGbCtD
Valsartan—CYP2C9—Dexamethasone—ulcerative colitis	0.0172	0.0639	CbGbCtD
Valsartan—Candesartan—PTGS1—ulcerative colitis	0.00127	0.32	CrCbGaD
Valsartan—Irbesartan—PTGS1—ulcerative colitis	0.00127	0.32	CrCbGaD
Valsartan—SLCO1B3—Recycling of bile acids and salts—ALB—ulcerative colitis	0.000853	0.0184	CbGpPWpGaD
Valsartan—AGTR1—Peptide GPCRs—CXCR2—ulcerative colitis	0.000804	0.0173	CbGpPWpGaD
Valsartan—SLCO1B1—Transport of organic anions—ALB—ulcerative colitis	0.000773	0.0166	CbGpPWpGaD
Valsartan—AGTR1—Peptide GPCRs—CCR6—ulcerative colitis	0.000756	0.0163	CbGpPWpGaD
Valsartan—AGTR1—Arf6 trafficking events—ADRB2—ulcerative colitis	0.000725	0.0156	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000693	0.0149	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—IL17A—ulcerative colitis	0.000622	0.0134	CbGpPWpGaD
Valsartan—Candesartan—ABCB1—ulcerative colitis	0.000616	0.155	CrCbGaD
Valsartan—AGTR1—ACE Inhibitor Pathway—TGFB1—ulcerative colitis	0.000589	0.0127	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—IL12B—ulcerative colitis	0.000578	0.0124	CbGpPWpGaD
Valsartan—SLCO1B1—Recycling of bile acids and salts—ALB—ulcerative colitis	0.000573	0.0123	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—CTLA4—ulcerative colitis	0.000543	0.0117	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—CXCR1—ulcerative colitis	0.000483	0.0104	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—HLA-DQA1—ulcerative colitis	0.000478	0.0103	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000466	0.01	CbGpPWpGaD
Valsartan—SLCO1B3—Bile acid and bile salt metabolism—ALB—ulcerative colitis	0.000446	0.00959	CbGpPWpGaD
Valsartan—AGTR1—Arf6 trafficking events—CDH1—ulcerative colitis	0.000438	0.00942	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—ABCB1—ulcerative colitis	0.000435	0.00937	CbGpPWpGaD
Valsartan—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—ALB—ulcerative colitis	0.000427	0.00919	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—CCL20—ulcerative colitis	0.000424	0.00913	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—IL10—ulcerative colitis	0.000423	0.0091	CbGpPWpGaD
Valsartan—Losartan—ALB—ulcerative colitis	0.000416	0.105	CrCbGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000409	0.0088	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000409	0.0088	CbGpPWpGaD
Valsartan—Losartan—ABCB1—ulcerative colitis	0.000397	0.1	CrCbGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	0.000378	0.00814	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—CXCR2—ulcerative colitis	0.000378	0.00814	CbGpPWpGaD
Valsartan—ALB—FOXA2 and FOXA3 transcription factor networks—HNF4A—ulcerative colitis	0.000373	0.00803	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—CCR6—ulcerative colitis	0.000355	0.00765	CbGpPWpGaD
Valsartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—RELA—ulcerative colitis	0.000354	0.00761	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000352	0.00758	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—HLA-DRB1—ulcerative colitis	0.00034	0.00732	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	0.000324	0.00697	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—MPO—ulcerative colitis	0.000321	0.00691	CbGpPWpGaD
Valsartan—SLCO1B1—Bile acid and bile salt metabolism—ALB—ulcerative colitis	0.000299	0.00644	CbGpPWpGaD
Valsartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—ulcerative colitis	0.000298	0.00642	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	0.000296	0.00637	CbGpPWpGaD
Valsartan—AGTR1—G alpha (q) signalling events—GHRL—ulcerative colitis	0.00029	0.00624	CbGpPWpGaD
Valsartan—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—ulcerative colitis	0.000287	0.00617	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—GHRL—ulcerative colitis	0.000286	0.00617	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	0.000284	0.00612	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	0.000278	0.00599	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000275	0.00591	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000275	0.00591	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000266	0.00573	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—MPO—ulcerative colitis	0.000261	0.00562	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—ulcerative colitis	0.000259	0.00559	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000255	0.00548	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	0.000254	0.00546	CbGpPWpGaD
Valsartan—AGTR1—Allograft Rejection—IFNG—ulcerative colitis	0.000249	0.00535	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CXCR1—ulcerative colitis	0.000247	0.00531	CbGpPWpGaD
Valsartan—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000246	0.00529	CbGpPWpGaD
Valsartan—CYP2C9—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000246	0.00529	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	0.000245	0.00527	CbGpPWpGaD
Valsartan—Hypersensitivity—Azathioprine—ulcerative colitis	0.000241	0.00111	CcSEcCtD
Valsartan—Dysgeusia—Triamcinolone—ulcerative colitis	0.000239	0.0011	CcSEcCtD
Valsartan—Vertigo—Prednisolone—ulcerative colitis	0.000239	0.0011	CcSEcCtD
Valsartan—Syncope—Prednisolone—ulcerative colitis	0.000238	0.0011	CcSEcCtD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	0.000238	0.00513	CbGpPWpGaD
Valsartan—Angioedema—Hydrocortisone—ulcerative colitis	0.000237	0.00109	CcSEcCtD
Valsartan—Urticaria—Mesalazine—ulcerative colitis	0.000237	0.00109	CcSEcCtD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000237	0.0051	CbGpPWpGaD
Valsartan—Back pain—Triamcinolone—ulcerative colitis	0.000237	0.00109	CcSEcCtD
Valsartan—Abdominal pain—Mesalazine—ulcerative colitis	0.000236	0.00109	CcSEcCtD
Valsartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000234	0.00504	CbGpPWpGaD
Valsartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000234	0.00503	CbGpPWpGaD
Valsartan—Loss of consciousness—Prednisolone—ulcerative colitis	0.000234	0.00108	CcSEcCtD
Valsartan—Vertigo—Hydrocortisone—ulcerative colitis	0.000233	0.00107	CcSEcCtD
Valsartan—Vomiting—Budesonide—ulcerative colitis	0.000233	0.00107	CcSEcCtD
Valsartan—Syncope—Hydrocortisone—ulcerative colitis	0.000233	0.00107	CcSEcCtD
Valsartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—ulcerative colitis	0.000232	0.00499	CbGpPWpGaD
Valsartan—Angiopathy—Dexamethasone—ulcerative colitis	0.000231	0.00107	CcSEcCtD
Valsartan—Angiopathy—Betamethasone—ulcerative colitis	0.000231	0.00107	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—CXCL8—ulcerative colitis	0.000231	0.00497	CbGpPWpGaD
Valsartan—Rash—Budesonide—ulcerative colitis	0.000231	0.00106	CcSEcCtD
Valsartan—Dermatitis—Budesonide—ulcerative colitis	0.000231	0.00106	CcSEcCtD
Valsartan—Headache—Budesonide—ulcerative colitis	0.00023	0.00106	CcSEcCtD
Valsartan—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000228	0.00105	CcSEcCtD
Valsartan—Alopecia—Dexamethasone—ulcerative colitis	0.000225	0.00104	CcSEcCtD
Valsartan—Alopecia—Betamethasone—ulcerative colitis	0.000225	0.00104	CcSEcCtD
Valsartan—Diarrhoea—Azathioprine—ulcerative colitis	0.000224	0.00103	CcSEcCtD
Valsartan—Angioedema—Triamcinolone—ulcerative colitis	0.000223	0.00103	CcSEcCtD
Valsartan—Haemoglobin—Prednisone—ulcerative colitis	0.000223	0.00103	CcSEcCtD
Valsartan—Angioedema—Methylprednisolone—ulcerative colitis	0.000223	0.00103	CcSEcCtD
Valsartan—Haemorrhage—Prednisone—ulcerative colitis	0.000222	0.00102	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—IL1B—ulcerative colitis	0.000222	0.00477	CbGpPWpGaD
Valsartan—Myalgia—Hydrocortisone—ulcerative colitis	0.000221	0.00102	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—IL2—ulcerative colitis	0.000221	0.00475	CbGpPWpGaD
Valsartan—Anxiety—Hydrocortisone—ulcerative colitis	0.00022	0.00101	CcSEcCtD
Valsartan—Vertigo—Triamcinolone—ulcerative colitis	0.00022	0.00101	CcSEcCtD
Valsartan—Hypersensitivity—Mesalazine—ulcerative colitis	0.00022	0.00101	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00022	0.00101	CcSEcCtD
Valsartan—Syncope—Triamcinolone—ulcerative colitis	0.000219	0.00101	CcSEcCtD
Valsartan—Vertigo—Methylprednisolone—ulcerative colitis	0.000219	0.00101	CcSEcCtD
Valsartan—Syncope—Methylprednisolone—ulcerative colitis	0.000219	0.00101	CcSEcCtD
Valsartan—Connective tissue disorder—Prednisone—ulcerative colitis	0.000218	0.001	CcSEcCtD
Valsartan—Nausea—Budesonide—ulcerative colitis	0.000218	0.001	CcSEcCtD
Valsartan—Oedema—Prednisolone—ulcerative colitis	0.000217	0.001	CcSEcCtD
Valsartan—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000217	0.001	CcSEcCtD
Valsartan—AGTR1—GPCR ligand binding—CCL20—ulcerative colitis	0.000217	0.00466	CbGpPWpGaD
Valsartan—Dizziness—Azathioprine—ulcerative colitis	0.000216	0.000997	CcSEcCtD
Valsartan—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000215	0.00099	CcSEcCtD
Valsartan—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000214	0.000988	CcSEcCtD
Valsartan—Asthenia—Mesalazine—ulcerative colitis	0.000214	0.000985	CcSEcCtD
Valsartan—Shock—Prednisolone—ulcerative colitis	0.000213	0.000983	CcSEcCtD
Valsartan—Cough—Triamcinolone—ulcerative colitis	0.000213	0.000983	CcSEcCtD
Valsartan—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000212	0.000976	CcSEcCtD
Valsartan—Oedema—Hydrocortisone—ulcerative colitis	0.000212	0.000976	CcSEcCtD
Valsartan—Pruritus—Mesalazine—ulcerative colitis	0.000211	0.000971	CcSEcCtD
Valsartan—Infection—Hydrocortisone—ulcerative colitis	0.000211	0.00097	CcSEcCtD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	0.00021	0.00452	CbGpPWpGaD
Valsartan—Shock—Hydrocortisone—ulcerative colitis	0.000209	0.00096	CcSEcCtD
Valsartan—Myalgia—Triamcinolone—ulcerative colitis	0.000208	0.000959	CcSEcCtD
Valsartan—Vomiting—Azathioprine—ulcerative colitis	0.000208	0.000958	CcSEcCtD
Valsartan—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000208	0.000957	CcSEcCtD
Valsartan—Myalgia—Methylprednisolone—ulcerative colitis	0.000208	0.000957	CcSEcCtD
Valsartan—Arthralgia—Methylprednisolone—ulcerative colitis	0.000208	0.000957	CcSEcCtD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.000208	0.00447	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000208	0.00447	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—MPO—ulcerative colitis	0.000208	0.00447	CbGpPWpGaD
Valsartan—Anxiety—Methylprednisolone—ulcerative colitis	0.000207	0.000953	CcSEcCtD
Valsartan—Rash—Azathioprine—ulcerative colitis	0.000206	0.00095	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000206	0.00095	CcSEcCtD
Valsartan—Dermatitis—Azathioprine—ulcerative colitis	0.000206	0.000949	CcSEcCtD
Valsartan—Skin disorder—Hydrocortisone—ulcerative colitis	0.000206	0.000948	CcSEcCtD
Valsartan—Headache—Azathioprine—ulcerative colitis	0.000205	0.000944	CcSEcCtD
Valsartan—Diarrhoea—Mesalazine—ulcerative colitis	0.000204	0.000939	CcSEcCtD
Valsartan—Dry mouth—Triamcinolone—ulcerative colitis	0.000204	0.000938	CcSEcCtD
Valsartan—Angioedema—Dexamethasone—ulcerative colitis	0.000203	0.000934	CcSEcCtD
Valsartan—Angioedema—Betamethasone—ulcerative colitis	0.000203	0.000934	CcSEcCtD
Valsartan—Anorexia—Hydrocortisone—ulcerative colitis	0.000202	0.000931	CcSEcCtD
Valsartan—Angiopathy—Prednisone—ulcerative colitis	0.000201	0.000928	CcSEcCtD
Valsartan—Immune system disorder—Prednisone—ulcerative colitis	0.0002	0.000923	CcSEcCtD
Valsartan—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.0002	0.000919	CcSEcCtD
Valsartan—Oedema—Triamcinolone—ulcerative colitis	0.0002	0.000919	CcSEcCtD
Valsartan—Vertigo—Betamethasone—ulcerative colitis	0.000199	0.000918	CcSEcCtD
Valsartan—Vertigo—Dexamethasone—ulcerative colitis	0.000199	0.000918	CcSEcCtD
Valsartan—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000199	0.000917	CcSEcCtD
Valsartan—Syncope—Dexamethasone—ulcerative colitis	0.000199	0.000917	CcSEcCtD
Valsartan—Syncope—Betamethasone—ulcerative colitis	0.000199	0.000917	CcSEcCtD
Valsartan—Infection—Triamcinolone—ulcerative colitis	0.000198	0.000913	CcSEcCtD
Valsartan—Hypotension—Hydrocortisone—ulcerative colitis	0.000198	0.000912	CcSEcCtD
Valsartan—Infection—Methylprednisolone—ulcerative colitis	0.000198	0.000911	CcSEcCtD
Valsartan—Dizziness—Mesalazine—ulcerative colitis	0.000197	0.000908	CcSEcCtD
Valsartan—Shock—Triamcinolone—ulcerative colitis	0.000196	0.000904	CcSEcCtD
Valsartan—Insomnia—Prednisolone—ulcerative colitis	0.000196	0.000904	CcSEcCtD
Valsartan—Alopecia—Prednisone—ulcerative colitis	0.000196	0.000903	CcSEcCtD
Valsartan—Shock—Methylprednisolone—ulcerative colitis	0.000196	0.000902	CcSEcCtD
Valsartan—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000195	0.000899	CcSEcCtD
Valsartan—Loss of consciousness—Betamethasone—ulcerative colitis	0.000195	0.000898	CcSEcCtD
Valsartan—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000195	0.000898	CcSEcCtD
Valsartan—Paraesthesia—Prednisolone—ulcerative colitis	0.000195	0.000898	CcSEcCtD
Valsartan—Mental disorder—Prednisone—ulcerative colitis	0.000194	0.000896	CcSEcCtD
Valsartan—Nausea—Azathioprine—ulcerative colitis	0.000194	0.000895	CcSEcCtD
Valsartan—Skin disorder—Methylprednisolone—ulcerative colitis	0.000193	0.000891	CcSEcCtD
Valsartan—Malnutrition—Prednisone—ulcerative colitis	0.000193	0.00089	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000193	0.000889	CcSEcCtD
Valsartan—AGTR1—GPCR ligand binding—CXCR2—ulcerative colitis	0.000193	0.00416	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	0.000192	0.00414	CbGpPWpGaD
Valsartan—Insomnia—Hydrocortisone—ulcerative colitis	0.000192	0.000883	CcSEcCtD
Valsartan—ALB—Selenium Micronutrient Network—PTGS1—ulcerative colitis	0.000191	0.00411	CbGpPWpGaD
Valsartan—Paraesthesia—Hydrocortisone—ulcerative colitis	0.00019	0.000877	CcSEcCtD
Valsartan—Vomiting—Mesalazine—ulcerative colitis	0.000189	0.000873	CcSEcCtD
Valsartan—Myalgia—Betamethasone—ulcerative colitis	0.000189	0.00087	CcSEcCtD
Valsartan—Myalgia—Dexamethasone—ulcerative colitis	0.000189	0.00087	CcSEcCtD
Valsartan—Anxiety—Dexamethasone—ulcerative colitis	0.000188	0.000867	CcSEcCtD
Valsartan—Anxiety—Betamethasone—ulcerative colitis	0.000188	0.000867	CcSEcCtD
Valsartan—Rash—Mesalazine—ulcerative colitis	0.000188	0.000866	CcSEcCtD
Valsartan—Dermatitis—Mesalazine—ulcerative colitis	0.000188	0.000865	CcSEcCtD
Valsartan—Headache—Mesalazine—ulcerative colitis	0.000187	0.00086	CcSEcCtD
Valsartan—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000187	0.000859	CcSEcCtD
Valsartan—Hypotension—Methylprednisolone—ulcerative colitis	0.000186	0.000857	CcSEcCtD
Valsartan—ALB—Platelet degranulation—CALM3—ulcerative colitis	0.000186	0.004	CbGpPWpGaD
Valsartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	0.000186	0.004	CbGpPWpGaD
Valsartan—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000184	0.000849	CcSEcCtD
Valsartan—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000183	0.000843	CcSEcCtD
Valsartan—Fatigue—Hydrocortisone—ulcerative colitis	0.000183	0.000842	CcSEcCtD
Valsartan—Vision blurred—Prednisone—ulcerative colitis	0.000182	0.000839	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000182	0.000838	CcSEcCtD
Valsartan—AGTR1—GPCR ligand binding—CCR6—ulcerative colitis	0.000182	0.00391	CbGpPWpGaD
Valsartan—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000181	0.000836	CcSEcCtD
Valsartan—Oedema—Betamethasone—ulcerative colitis	0.000181	0.000834	CcSEcCtD
Valsartan—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000181	0.000834	CcSEcCtD
Valsartan—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000181	0.000834	CcSEcCtD
Valsartan—Oedema—Dexamethasone—ulcerative colitis	0.000181	0.000834	CcSEcCtD
Valsartan—Insomnia—Triamcinolone—ulcerative colitis	0.00018	0.000831	CcSEcCtD
Valsartan—Insomnia—Methylprednisolone—ulcerative colitis	0.00018	0.00083	CcSEcCtD
Valsartan—Infection—Dexamethasone—ulcerative colitis	0.00018	0.000829	CcSEcCtD
Valsartan—Infection—Betamethasone—ulcerative colitis	0.00018	0.000829	CcSEcCtD
Valsartan—Paraesthesia—Triamcinolone—ulcerative colitis	0.000179	0.000825	CcSEcCtD
Valsartan—Paraesthesia—Methylprednisolone—ulcerative colitis	0.000179	0.000824	CcSEcCtD
Valsartan—Shock—Dexamethasone—ulcerative colitis	0.000178	0.000821	CcSEcCtD
Valsartan—Shock—Betamethasone—ulcerative colitis	0.000178	0.000821	CcSEcCtD
Valsartan—Dyspnoea—Triamcinolone—ulcerative colitis	0.000178	0.00082	CcSEcCtD
Valsartan—Nervous system disorder—Betamethasone—ulcerative colitis	0.000178	0.000818	CcSEcCtD
Valsartan—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000178	0.000818	CcSEcCtD
Valsartan—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000177	0.000817	CcSEcCtD
Valsartan—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000177	0.000817	CcSEcCtD
Valsartan—Nausea—Mesalazine—ulcerative colitis	0.000177	0.000815	CcSEcCtD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—CALM3—ulcerative colitis	0.000177	0.00381	CbGpPWpGaD
Valsartan—Angioedema—Prednisone—ulcerative colitis	0.000177	0.000813	CcSEcCtD
Valsartan—Dyspepsia—Triamcinolone—ulcerative colitis	0.000176	0.000809	CcSEcCtD
Valsartan—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000175	0.000807	CcSEcCtD
Valsartan—Vertigo—Prednisone—ulcerative colitis	0.000174	0.0008	CcSEcCtD
Valsartan—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000173	0.000798	CcSEcCtD
Valsartan—Syncope—Prednisone—ulcerative colitis	0.000173	0.000798	CcSEcCtD
Valsartan—Anorexia—Betamethasone—ulcerative colitis	0.000173	0.000795	CcSEcCtD
Valsartan—Anorexia—Dexamethasone—ulcerative colitis	0.000173	0.000795	CcSEcCtD
Valsartan—Urticaria—Prednisolone—ulcerative colitis	0.000172	0.000794	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—TGFB1—ulcerative colitis	0.000172	0.00371	CbGpPWpGaD
Valsartan—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000172	0.00371	CbGpPWpGaD
Valsartan—Fatigue—Triamcinolone—ulcerative colitis	0.000172	0.000793	CcSEcCtD
Valsartan—Fatigue—Methylprednisolone—ulcerative colitis	0.000172	0.000791	CcSEcCtD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000171	0.00368	CbGpPWpGaD
Valsartan—Loss of consciousness—Prednisone—ulcerative colitis	0.00017	0.000782	CcSEcCtD
Valsartan—Hypotension—Betamethasone—ulcerative colitis	0.000169	0.000779	CcSEcCtD
Valsartan—Hypotension—Dexamethasone—ulcerative colitis	0.000169	0.000779	CcSEcCtD
Valsartan—ALB—Vitamin B12 Metabolism—CRP—ulcerative colitis	0.000169	0.00364	CbGpPWpGaD
Valsartan—Urticaria—Hydrocortisone—ulcerative colitis	0.000168	0.000776	CcSEcCtD
Valsartan—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000168	0.000772	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000165	0.00076	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000165	0.00076	CcSEcCtD
Valsartan—Myalgia—Prednisone—ulcerative colitis	0.000164	0.000758	CcSEcCtD
Valsartan—Arthralgia—Prednisone—ulcerative colitis	0.000164	0.000758	CcSEcCtD
Valsartan—Anxiety—Prednisone—ulcerative colitis	0.000164	0.000755	CcSEcCtD
Valsartan—Insomnia—Betamethasone—ulcerative colitis	0.000164	0.000754	CcSEcCtD
Valsartan—Insomnia—Dexamethasone—ulcerative colitis	0.000164	0.000754	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000163	0.000753	CcSEcCtD
Valsartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000163	0.00351	CbGpPWpGaD
Valsartan—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000163	0.00075	CcSEcCtD
Valsartan—Paraesthesia—Betamethasone—ulcerative colitis	0.000163	0.000749	CcSEcCtD
Valsartan—Paraesthesia—Dexamethasone—ulcerative colitis	0.000163	0.000749	CcSEcCtD
Valsartan—AGTR1—Allograft Rejection—TNF—ulcerative colitis	0.000161	0.00346	CbGpPWpGaD
Valsartan—Hypersensitivity—Prednisolone—ulcerative colitis	0.00016	0.000736	CcSEcCtD
Valsartan—AGTR1—GPCR ligand binding—PTGER4—ulcerative colitis	0.00016	0.00344	CbGpPWpGaD
Valsartan—Dyspepsia—Dexamethasone—ulcerative colitis	0.000159	0.000734	CcSEcCtD
Valsartan—Dyspepsia—Betamethasone—ulcerative colitis	0.000159	0.000734	CcSEcCtD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	0.000159	0.00342	CbGpPWpGaD
Valsartan—Urticaria—Triamcinolone—ulcerative colitis	0.000159	0.00073	CcSEcCtD
Valsartan—Urticaria—Methylprednisolone—ulcerative colitis	0.000158	0.000729	CcSEcCtD
Valsartan—Anaphylactic shock—Prednisone—ulcerative colitis	0.000158	0.000726	CcSEcCtD
Valsartan—Oedema—Prednisone—ulcerative colitis	0.000158	0.000726	CcSEcCtD
Valsartan—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000157	0.000725	CcSEcCtD
Valsartan—Decreased appetite—Dexamethasone—ulcerative colitis	0.000157	0.000725	CcSEcCtD
Valsartan—Decreased appetite—Betamethasone—ulcerative colitis	0.000157	0.000725	CcSEcCtD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000157	0.00338	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000157	0.00338	CbGpPWpGaD
Valsartan—Infection—Prednisone—ulcerative colitis	0.000157	0.000722	CcSEcCtD
Valsartan—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000156	0.00072	CcSEcCtD
Valsartan—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000156	0.00072	CcSEcCtD
Valsartan—ALB—Hemostasis—PROCR—ulcerative colitis	0.000156	0.00336	CbGpPWpGaD
Valsartan—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000156	0.000719	CcSEcCtD
Valsartan—Fatigue—Betamethasone—ulcerative colitis	0.000156	0.000719	CcSEcCtD
Valsartan—Fatigue—Dexamethasone—ulcerative colitis	0.000156	0.000719	CcSEcCtD
Valsartan—ALB—Vitamin B12 Metabolism—ICAM1—ulcerative colitis	0.000155	0.00334	CbGpPWpGaD
Valsartan—Shock—Prednisone—ulcerative colitis	0.000155	0.000715	CcSEcCtD
Valsartan—Nervous system disorder—Prednisone—ulcerative colitis	0.000155	0.000712	CcSEcCtD
Valsartan—Skin disorder—Prednisone—ulcerative colitis	0.000153	0.000706	CcSEcCtD
Valsartan—Asthenia—Hydrocortisone—ulcerative colitis	0.000152	0.0007	CcSEcCtD
Valsartan—Anorexia—Prednisone—ulcerative colitis	0.00015	0.000692	CcSEcCtD
Valsartan—Pruritus—Hydrocortisone—ulcerative colitis	0.00015	0.000691	CcSEcCtD
Valsartan—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000148	0.000682	CcSEcCtD
Valsartan—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000148	0.000682	CcSEcCtD
Valsartan—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000147	0.000677	CcSEcCtD
Valsartan—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000147	0.000676	CcSEcCtD
Valsartan—AGTR1—GPCR ligand binding—GHRL—ulcerative colitis	0.000146	0.00315	CbGpPWpGaD
Valsartan—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000145	0.000668	CcSEcCtD
Valsartan—Urticaria—Betamethasone—ulcerative colitis	0.000144	0.000663	CcSEcCtD
Valsartan—Urticaria—Dexamethasone—ulcerative colitis	0.000144	0.000663	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000144	0.000662	CcSEcCtD
Valsartan—Dizziness—Prednisolone—ulcerative colitis	0.000143	0.000661	CcSEcCtD
Valsartan—Asthenia—Triamcinolone—ulcerative colitis	0.000143	0.00066	CcSEcCtD
Valsartan—Abdominal pain—Dexamethasone—ulcerative colitis	0.000143	0.000659	CcSEcCtD
Valsartan—Abdominal pain—Betamethasone—ulcerative colitis	0.000143	0.000659	CcSEcCtD
Valsartan—Asthenia—Methylprednisolone—ulcerative colitis	0.000143	0.000658	CcSEcCtD
Valsartan—Insomnia—Prednisone—ulcerative colitis	0.000143	0.000657	CcSEcCtD
Valsartan—Paraesthesia—Prednisone—ulcerative colitis	0.000142	0.000652	CcSEcCtD
Valsartan—Pruritus—Triamcinolone—ulcerative colitis	0.000141	0.00065	CcSEcCtD
Valsartan—Pruritus—Methylprednisolone—ulcerative colitis	0.000141	0.000649	CcSEcCtD
Valsartan—Dizziness—Hydrocortisone—ulcerative colitis	0.00014	0.000646	CcSEcCtD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.00014	0.003	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	0.00014	0.003	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCR1—ulcerative colitis	0.000139	0.003	CbGpPWpGaD
Valsartan—Dyspepsia—Prednisone—ulcerative colitis	0.000139	0.000639	CcSEcCtD
Valsartan—ALB—Folate Metabolism—CRP—ulcerative colitis	0.000137	0.00296	CbGpPWpGaD
Valsartan—Decreased appetite—Prednisone—ulcerative colitis	0.000137	0.000631	CcSEcCtD
Valsartan—Rash—Prednisolone—ulcerative colitis	0.000137	0.00063	CcSEcCtD
Valsartan—Dermatitis—Prednisolone—ulcerative colitis	0.000137	0.00063	CcSEcCtD
Valsartan—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000136	0.000628	CcSEcCtD
Valsartan—Fatigue—Prednisone—ulcerative colitis	0.000136	0.000626	CcSEcCtD
Valsartan—Headache—Prednisolone—ulcerative colitis	0.000136	0.000626	CcSEcCtD
Valsartan—ALB—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000135	0.00291	CbGpPWpGaD
Valsartan—Constipation—Prednisone—ulcerative colitis	0.000135	0.000621	CcSEcCtD
Valsartan—Vomiting—Hydrocortisone—ulcerative colitis	0.000135	0.000621	CcSEcCtD
Valsartan—Rash—Hydrocortisone—ulcerative colitis	0.000134	0.000616	CcSEcCtD
Valsartan—Dermatitis—Hydrocortisone—ulcerative colitis	0.000133	0.000615	CcSEcCtD
Valsartan—Headache—Hydrocortisone—ulcerative colitis	0.000133	0.000612	CcSEcCtD
Valsartan—Dizziness—Triamcinolone—ulcerative colitis	0.000132	0.000608	CcSEcCtD
Valsartan—Dizziness—Methylprednisolone—ulcerative colitis	0.000132	0.000607	CcSEcCtD
Valsartan—Asthenia—Betamethasone—ulcerative colitis	0.00013	0.000598	CcSEcCtD
Valsartan—Asthenia—Dexamethasone—ulcerative colitis	0.00013	0.000598	CcSEcCtD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	0.000129	0.00278	CbGpPWpGaD
Valsartan—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000129	0.000594	CcSEcCtD
Valsartan—Nausea—Prednisolone—ulcerative colitis	0.000129	0.000594	CcSEcCtD
Valsartan—Pruritus—Dexamethasone—ulcerative colitis	0.000128	0.00059	CcSEcCtD
Valsartan—Pruritus—Betamethasone—ulcerative colitis	0.000128	0.00059	CcSEcCtD
Valsartan—Vomiting—Triamcinolone—ulcerative colitis	0.000127	0.000584	CcSEcCtD
Valsartan—AGTR1—Signaling by GPCR—CXCR1—ulcerative colitis	0.000127	0.00273	CbGpPWpGaD
Valsartan—Vomiting—Methylprednisolone—ulcerative colitis	0.000127	0.000583	CcSEcCtD
Valsartan—ALB—Folate Metabolism—ICAM1—ulcerative colitis	0.000126	0.00272	CbGpPWpGaD
Valsartan—Nausea—Hydrocortisone—ulcerative colitis	0.000126	0.00058	CcSEcCtD
Valsartan—Rash—Triamcinolone—ulcerative colitis	0.000126	0.00058	CcSEcCtD
Valsartan—Dermatitis—Triamcinolone—ulcerative colitis	0.000126	0.000579	CcSEcCtD
Valsartan—Rash—Methylprednisolone—ulcerative colitis	0.000126	0.000578	CcSEcCtD
Valsartan—Dermatitis—Methylprednisolone—ulcerative colitis	0.000125	0.000578	CcSEcCtD
Valsartan—Urticaria—Prednisone—ulcerative colitis	0.000125	0.000577	CcSEcCtD
Valsartan—Headache—Triamcinolone—ulcerative colitis	0.000125	0.000576	CcSEcCtD
Valsartan—Headache—Methylprednisolone—ulcerative colitis	0.000125	0.000575	CcSEcCtD
Valsartan—Abdominal pain—Prednisone—ulcerative colitis	0.000125	0.000574	CcSEcCtD
Valsartan—Diarrhoea—Dexamethasone—ulcerative colitis	0.000124	0.000571	CcSEcCtD
Valsartan—Diarrhoea—Betamethasone—ulcerative colitis	0.000124	0.000571	CcSEcCtD
Valsartan—AGTR1—GPCR downstream signaling—CCL20—ulcerative colitis	0.000122	0.00263	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—ADRB2—ulcerative colitis	0.000121	0.00261	CbGpPWpGaD
Valsartan—Dizziness—Betamethasone—ulcerative colitis	0.00012	0.000552	CcSEcCtD
Valsartan—Dizziness—Dexamethasone—ulcerative colitis	0.00012	0.000552	CcSEcCtD
Valsartan—SLCO1B3—Metabolism—CHP1—ulcerative colitis	0.000119	0.00257	CbGpPWpGaD
Valsartan—Nausea—Triamcinolone—ulcerative colitis	0.000119	0.000546	CcSEcCtD
Valsartan—ALB—Platelet activation, signaling and aggregation—GNA12—ulcerative colitis	0.000118	0.00255	CbGpPWpGaD
Valsartan—Nausea—Methylprednisolone—ulcerative colitis	0.000118	0.000545	CcSEcCtD
Valsartan—ALB—Vitamin B12 Metabolism—IFNG—ulcerative colitis	0.000118	0.00254	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—RELA—ulcerative colitis	0.000117	0.00251	CbGpPWpGaD
Valsartan—Hypersensitivity—Prednisone—ulcerative colitis	0.000116	0.000535	CcSEcCtD
Valsartan—Vomiting—Dexamethasone—ulcerative colitis	0.000115	0.00053	CcSEcCtD
Valsartan—Vomiting—Betamethasone—ulcerative colitis	0.000115	0.00053	CcSEcCtD
Valsartan—AGTR1—GPCR downstream signaling—GNA12—ulcerative colitis	0.000115	0.00248	CbGpPWpGaD
Valsartan—AGTR1—Peptide ligand-binding receptors—CXCL8—ulcerative colitis	0.000115	0.00247	CbGpPWpGaD
Valsartan—Rash—Betamethasone—ulcerative colitis	0.000114	0.000526	CcSEcCtD
Valsartan—Rash—Dexamethasone—ulcerative colitis	0.000114	0.000526	CcSEcCtD
Valsartan—Dermatitis—Dexamethasone—ulcerative colitis	0.000114	0.000525	CcSEcCtD
Valsartan—Dermatitis—Betamethasone—ulcerative colitis	0.000114	0.000525	CcSEcCtD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—ulcerative colitis	0.000114	0.00245	CbGpPWpGaD
Valsartan—Headache—Betamethasone—ulcerative colitis	0.000113	0.000523	CcSEcCtD
Valsartan—Headache—Dexamethasone—ulcerative colitis	0.000113	0.000523	CcSEcCtD
Valsartan—Asthenia—Prednisone—ulcerative colitis	0.000113	0.000521	CcSEcCtD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	0.000112	0.00241	CbGpPWpGaD
Valsartan—Pruritus—Prednisone—ulcerative colitis	0.000112	0.000514	CcSEcCtD
Valsartan—AGTR1—Signaling by GPCR—CCL20—ulcerative colitis	0.000111	0.00239	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—CRP—ulcerative colitis	0.000109	0.00235	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCR2—ulcerative colitis	0.000109	0.00235	CbGpPWpGaD
Valsartan—Diarrhoea—Prednisone—ulcerative colitis	0.000108	0.000497	CcSEcCtD
Valsartan—Nausea—Dexamethasone—ulcerative colitis	0.000108	0.000495	CcSEcCtD
Valsartan—Nausea—Betamethasone—ulcerative colitis	0.000108	0.000495	CcSEcCtD
Valsartan—ALB—Vitamin B12 Metabolism—IL1B—ulcerative colitis	0.000105	0.00227	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—GNA12—ulcerative colitis	0.000105	0.00225	CbGpPWpGaD
Valsartan—Dizziness—Prednisone—ulcerative colitis	0.000104	0.00048	CcSEcCtD
Valsartan—SLCO1B3—Metabolism—DLD—ulcerative colitis	0.000103	0.00222	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CCR6—ulcerative colitis	0.000103	0.00221	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—ICAM1—ulcerative colitis	0.0001	0.00216	CbGpPWpGaD
Valsartan—Vomiting—Prednisone—ulcerative colitis	0.0001	0.000462	CcSEcCtD
Valsartan—Rash—Prednisone—ulcerative colitis	9.94e-05	0.000458	CcSEcCtD
Valsartan—Dermatitis—Prednisone—ulcerative colitis	9.93e-05	0.000458	CcSEcCtD
Valsartan—AGTR1—Signaling by GPCR—CXCR2—ulcerative colitis	9.91e-05	0.00213	CbGpPWpGaD
Valsartan—Headache—Prednisone—ulcerative colitis	9.88e-05	0.000455	CcSEcCtD
Valsartan—ALB—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	9.83e-05	0.00212	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	9.77e-05	0.0021	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IFNG—ulcerative colitis	9.61e-05	0.00207	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—RELA—ulcerative colitis	9.48e-05	0.00204	CbGpPWpGaD
Valsartan—CYP2C9—Arachidonic acid metabolism—PTGS2—ulcerative colitis	9.42e-05	0.00203	CbGpPWpGaD
Valsartan—Nausea—Prednisone—ulcerative colitis	9.37e-05	0.000431	CcSEcCtD
Valsartan—AGTR1—Signaling by GPCR—CCR6—ulcerative colitis	9.32e-05	0.00201	CbGpPWpGaD
Valsartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—ulcerative colitis	9.16e-05	0.00197	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—PTGS1—ulcerative colitis	9.15e-05	0.00197	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—SEL1L—ulcerative colitis	9.08e-05	0.00196	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—PTGER4—ulcerative colitis	9.03e-05	0.00194	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	8.69e-05	0.00187	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL1B—ulcerative colitis	8.57e-05	0.00185	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL2—ulcerative colitis	8.54e-05	0.00184	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—GHRL—ulcerative colitis	8.27e-05	0.00178	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—CALM3—ulcerative colitis	8.23e-05	0.00177	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PTGER4—ulcerative colitis	8.2e-05	0.00177	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CHP1—ulcerative colitis	8.02e-05	0.00173	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—NFKB1—ulcerative colitis	8e-05	0.00172	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	7.97e-05	0.00172	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	7.97e-05	0.00172	CbGpPWpGaD
Valsartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	7.68e-05	0.00165	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—TNF—ulcerative colitis	7.65e-05	0.00165	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IFNG—ulcerative colitis	7.64e-05	0.00164	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—RELA—ulcerative colitis	7.53e-05	0.00162	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	7.51e-05	0.00162	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—GHRL—ulcerative colitis	7.51e-05	0.00162	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCR1—ulcerative colitis	7.48e-05	0.00161	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	7.44e-05	0.0016	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—PTGS2—ulcerative colitis	7.32e-05	0.00158	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CALM3—ulcerative colitis	7.27e-05	0.00157	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	6.94e-05	0.00149	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DLD—ulcerative colitis	6.92e-05	0.00149	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—ADRB2—ulcerative colitis	6.84e-05	0.00147	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL1B—ulcerative colitis	6.81e-05	0.00147	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCL20—ulcerative colitis	6.57e-05	0.00141	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—NFKB1—ulcerative colitis	6.35e-05	0.00137	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TNF—ulcerative colitis	6.22e-05	0.00134	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—ADRB2—ulcerative colitis	6.22e-05	0.00134	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GNA12—ulcerative colitis	6.17e-05	0.00133	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—IL6—ulcerative colitis	6.17e-05	0.00133	CbGpPWpGaD
Valsartan—SLCO1B1—SLC-mediated transmembrane transport—ALB—ulcerative colitis	6.16e-05	0.00133	CbGpPWpGaD
Valsartan—ALB—Hemostasis—GNA12—ulcerative colitis	6.1e-05	0.00131	CbGpPWpGaD
Valsartan—ALB—Hemostasis—ITGAL—ulcerative colitis	5.99e-05	0.00129	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCR2—ulcerative colitis	5.85e-05	0.00126	CbGpPWpGaD
Valsartan—AGTR1—GPCR ligand binding—CXCL8—ulcerative colitis	5.85e-05	0.00126	CbGpPWpGaD
Valsartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	5.83e-05	0.00125	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—ADCY5—ulcerative colitis	5.81e-05	0.00125	CbGpPWpGaD
Valsartan—ALB—Platelet degranulation—TGFB1—ulcerative colitis	5.71e-05	0.00123	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCR6—ulcerative colitis	5.5e-05	0.00118	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TP53—ulcerative colitis	5.48e-05	0.00118	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.45e-05	0.00117	CbGpPWpGaD
Valsartan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ulcerative colitis	5.44e-05	0.00117	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—ADCY5—ulcerative colitis	5.28e-05	0.00114	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MAML2—ulcerative colitis	5.22e-05	0.00112	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—IL6—ulcerative colitis	5.02e-05	0.00108	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	5e-05	0.00108	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTGS1—ulcerative colitis	4.98e-05	0.00107	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	4.96e-05	0.00107	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—TNF—ulcerative colitis	4.94e-05	0.00106	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	4.9e-05	0.00105	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PTGER4—ulcerative colitis	4.84e-05	0.00104	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.67e-05	0.001	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ALB—ulcerative colitis	4.66e-05	0.001	CbGpPWpGaD
Valsartan—ALB—Metabolism—CHP1—ulcerative colitis	4.58e-05	0.000986	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CALM3—ulcerative colitis	4.48e-05	0.000965	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GHRL—ulcerative colitis	4.44e-05	0.000955	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CALM3—ulcerative colitis	4.3e-05	0.000925	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	4.29e-05	0.000924	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.28e-05	0.000922	CbGpPWpGaD
Valsartan—ALB—Hemostasis—CALM3—ulcerative colitis	4.24e-05	0.000914	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RIPK2—ulcerative colitis	4.23e-05	0.000911	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL6—ulcerative colitis	3.99e-05	0.000859	CbGpPWpGaD
Valsartan—ALB—Metabolism—DLD—ulcerative colitis	3.95e-05	0.000851	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CHP1—ulcerative colitis	3.75e-05	0.000807	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—JAK2—ulcerative colitis	3.72e-05	0.000802	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADRB2—ulcerative colitis	3.67e-05	0.00079	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	3.66e-05	0.000788	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—JAK2—ulcerative colitis	3.62e-05	0.00078	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.51e-05	0.000756	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ABCB1—ulcerative colitis	3.49e-05	0.00075	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGS1—ulcerative colitis	3.35e-05	0.00072	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—CXCL8—ulcerative colitis	3.31e-05	0.000712	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	3.29e-05	0.000708	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—JAK2—ulcerative colitis	3.29e-05	0.000708	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ADCY5—ulcerative colitis	3.25e-05	0.0007	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—IL2—ulcerative colitis	3.25e-05	0.000699	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DLD—ulcerative colitis	3.24e-05	0.000697	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—IL2—ulcerative colitis	3.16e-05	0.00068	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ALB—ulcerative colitis	3.13e-05	0.000673	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADCY5—ulcerative colitis	3.12e-05	0.000671	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CALM3—ulcerative colitis	3.01e-05	0.000648	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CXCL8—ulcerative colitis	3e-05	0.000646	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	2.88e-05	0.00062	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL2—ulcerative colitis	2.87e-05	0.000618	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.86e-05	0.000615	CbGpPWpGaD
Valsartan—ALB—Hemostasis—MMP1—ulcerative colitis	2.72e-05	0.000586	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.67e-05	0.000574	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—TGFB1—ulcerative colitis	2.53e-05	0.000545	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PPARG—ulcerative colitis	2.43e-05	0.000522	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ABCB1—ulcerative colitis	2.34e-05	0.000504	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ADCY5—ulcerative colitis	2.19e-05	0.00047	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ALB—ulcerative colitis	2.18e-05	0.000469	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	2.09e-05	0.00045	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—JAK2—ulcerative colitis	1.94e-05	0.000418	CbGpPWpGaD
Valsartan—ALB—Hemostasis—JAK2—ulcerative colitis	1.92e-05	0.000413	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS1—ulcerative colitis	1.91e-05	0.000411	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PTGS2—ulcerative colitis	1.91e-05	0.000411	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—RELA—ulcerative colitis	1.88e-05	0.000405	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CXCL8—ulcerative colitis	1.77e-05	0.000382	CbGpPWpGaD
Valsartan—ALB—Metabolism—CALM3—ulcerative colitis	1.72e-05	0.00037	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.71e-05	0.000368	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL2—ulcerative colitis	1.69e-05	0.000365	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—IL6—ulcerative colitis	1.69e-05	0.000363	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL2—ulcerative colitis	1.67e-05	0.00036	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.64e-05	0.000354	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PPARG—ulcerative colitis	1.63e-05	0.000351	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MMP9—ulcerative colitis	1.6e-05	0.000345	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NFKB1—ulcerative colitis	1.59e-05	0.000342	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS1—ulcerative colitis	1.56e-05	0.000337	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.54e-05	0.000331	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ALB—ulcerative colitis	1.47e-05	0.000315	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—STAT3—ulcerative colitis	1.43e-05	0.000307	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CALM3—ulcerative colitis	1.41e-05	0.000303	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.35e-05	0.00029	CbGpPWpGaD
Valsartan—ALB—Metabolism—ABCB1—ulcerative colitis	1.34e-05	0.000288	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TGFB1—ulcerative colitis	1.32e-05	0.000285	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TGFB1—ulcerative colitis	1.31e-05	0.000281	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PTGS2—ulcerative colitis	1.28e-05	0.000276	CbGpPWpGaD
Valsartan—ALB—Metabolism—ADCY5—ulcerative colitis	1.25e-05	0.000269	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ABCB1—ulcerative colitis	1.1e-05	0.000236	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TP53—ulcerative colitis	1.09e-05	0.000234	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TP53—ulcerative colitis	1.08e-05	0.000231	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ADCY5—ulcerative colitis	1.02e-05	0.00022	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL6—ulcerative colitis	9.96e-06	0.000214	CbGpPWpGaD
Valsartan—ALB—Metabolism—PPARG—ulcerative colitis	9.31e-06	0.0002	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PPARG—ulcerative colitis	7.62e-06	0.000164	CbGpPWpGaD
Valsartan—ALB—Metabolism—PTGS2—ulcerative colitis	7.32e-06	0.000158	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ALB—ulcerative colitis	6.85e-06	0.000148	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PTGS2—ulcerative colitis	6e-06	0.000129	CbGpPWpGaD
